Trust Company’s Astrana Health ASTH Stock Holding History

Trust Company’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$464	Hold	10	–	–	﹤0.01%	777
2026 Q1	$245	Hold	10	–	–	﹤0.01%	854
2025 Q4	$248	Buy	+10	New	+$266	﹤0.01%	847

Other funds holding ASTH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

325 Capital New York $419M AUM 75.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Trust Company's ASTH Position: Q2 2026 in Review

Trust Company held its Astrana Health (ASTH) position steady in Q2 2026 at 10 shares worth $464. The position accounts for ﹤0.01% of the portfolio, ranked #777.

Trust Company first reported a position in ASTH in Q4 2025 and has held it in 3 quarters since. 210 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

Trust Company held 10 shares of Astrana Health worth $464 as of Q2 2026.
Trust Company left its Astrana Health share count unchanged in Q2 2026.
Astrana Health made up ﹤0.01% of Trust Company's portfolio in Q2 2026, its #777 holding.
Trust Company first reported a position in Astrana Health in Q4 2025 and has held it in 3 quarters since.
210 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.